Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Liver Health Education Gets The Silent Treatment
Liver health education seems to be absent from the final draft of the National Academy of Science's Strategy for Eliminating Viral Hepatitis B & C.
Examining HCV Burden in EU and Measures to Eradicate it by 2030
Researchers from the Center for Disease Analysis investigated the incidence of hepatitis C in the European Union (EU) and examined the measures that would be needed to achieve the World Health Organization’s ultimate goal of eradicating the disease by 2030.
Doctors Without Borders Among 30 Groups to Challenge HCV Drug Patent in Europe
Doctors Without Borders and humanitarian groups across Europe are coordinating their opposition to Gilead Sciences Inc’s patent for hepatitis C treatment sofosbuvir, the basis for the biopharmaceutical giant’s Sovaldi, Harvoni, and Epclusa drugs.
FDA Approves New Indications for Two HCV Drugs
The US Food and Drug Administration just approved indications for two hepatitis C drugs to be used in pediatric patients.
Top 5 <i>Contagion</i>® News Articles for the Week of March 12, 2017
In case you missed them, our top 5 articles for the week of March 12, 2017 are highlighted here.
Exploring the Road to HIV-HCV Eradication in the DAA Era
Researchers posit that increased direct-acting antiviral (DAA) coverage can work to completely eradicate hepatitis c virus (HCV) in some populations of HIV-positive coinfected patients.
Hepatitis C and the Dwindling of Research Funding
Hepatitis C virus is the world’s most prevalent blood-borne viral infection for which a vaccine does not exist. To eliminate HCV infection on a global scale, experts argue that vaccine development needs to become a public health priority.
HCV Testing Remains Low Among High-Risk Population
When the US Preventive Services Task Force (USPSTF) recommended that all baby boomers undergo a one-time hepatitis C screening in 2013, testing prevalence increased. However, the rate is still lower than officials would like to see.